Forest Laboratories and Almirall announce commercial availability of Tudorzaâ„¢ Pressairâ„¢ in US pharmacies

Forest Laboratories and Almirall announce commercial availability of Tudorzaâ„¢ Pressairâ„¢ in US pharmacies

[at noodls] – NEW YORK & BARCELONA, Spain–(BUSINESS WIRE)–Forest Laboratories, Inc. (NYSE:FRX) and Almirall, S.A. (ALM:MC) announced today that Tudorzaâ„¢ Pressairâ„¢ (aclidinium bromide inhalation powder) 400mcg is now … more

View todays social media effects on FRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Forest is hiring next, click here to view

Share this post